Results 1 to 10 of about 243,517 (196)

Clinical scientist led clinic in adult congenital heart disease – how to do it? [PDF]

open access: yesEcho Research and Practice
The increasing demand for adult congenital heart disease (ACHD) services requires innovative solutions to reduce waiting times and optimise patient care.
Dario Freitas   +8 more
doaj   +2 more sources

Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease–Related Heart Failure

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background This study assessed trends in heart failure (HF) hospitalizations and health resource use in patients with adult congenital heart disease (ACHD).
Luke J. Burchill   +7 more
doaj   +2 more sources

Adult Congenital Heart Disease

open access: yesAnaesthesia & intensive care medicine, 2018
Congenital heart disease (CHD) is the most common congenital anomaly, affecting around 1–2% of newborns. Over the last generation, advances in medical, interventional, and surgical techniques have revolutionized the care of CHD patients. Most patients of
Leanne Groban, Chandrika Rajan Garner
openaire   +2 more sources

Limited Accuracy of Administrative Data for the Identification and Classification of Adult Congenital Heart Disease

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Administrative data sets utilize billing codes for research and quality assessment. Previous data suggest that such codes can accurately identify adults with congenital heart disease (CHD) in the cardiology clinic, but their use has yet to be ...
Abigail Khan   +7 more
doaj   +2 more sources

Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease

open access: yesIndian Pacing and Electrophysiology Journal, 2022
Background: Wearable cardioverter-defibrillators (WCDs) are currently used in patients at temporarily heightened risk for sudden cardiac death (SCD) who are temporarily unable to receive an implantable cardioverter-defibrillator (ICD).
Berardo Sarubbi   +10 more
doaj   +1 more source

Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years

open access: yesEuropace, 2023
This review article reflects how publications in EP Europace have contributed to advancing the science of management of arrhythmic disease in children and adult patients with congenital heart disease within the last 25 years.
T. Paul   +3 more
semanticscholar   +1 more source

Overview of Long-Term Outcome in Adults with Systemic Right Ventricle and Transposition of the Great Arteries: A Review

open access: yesDiagnostics, 2023
The population of patients with a systemic right ventricle (sRV) in biventricular circulation includes those who have undergone an atrial switch operation for destro-transposition of the great arteries (d-TGA) and those with congenitally corrected ...
Francesca Bevilacqua   +7 more
doaj   +1 more source

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2021
Background: Implantable cardioverter defibrillators (ICD) are widely accepted therapy in congenital heart disease (CHD) patients at risk of life-threatening ventricular arrhythmias or sudden cardiac death (SCD).
Berardo Sarubbi   +13 more
doaj   +1 more source

Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors

open access: yesESC Heart Failure, 2021
Information on the prevalence, outcome and factors associated with heart failure in patients with adult congenital heart disease (CHD) (ACHD‐HF) is lacking.
Stijn Arnaert   +14 more
semanticscholar   +1 more source

Protein-losing enteropathy in Fontan circulation: Pathophysiology, outcome and treatment options of a complex condition

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2022
Protein-losing enteropathy (PLE) represents a rare but severe and potentially life-threatening complication following Fontan operation in patients with a functional single ventricle.
Rosaria Barracano   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy